Scientists develop nanoantidote to reduce acidosis in critically ill COVID-19 patients

A group of scientists from China has recently developed an antacid nanoantidote that can effectively ameliorate blood acidosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study has been published in the journal VIEW.